2023-04-102024-03-312024-03-31false14789436RL DENTAL LIMITED2024-07-31iso4217:GBPxbrli:pure147894362023-04-10147894362024-03-31147894362023-04-102024-03-31147894362023-04-09147894362023-04-09147894362023-04-092023-04-0914789436bus:SmallEntities2023-04-102024-03-3114789436bus:AuditExempt-NoAccountantsReport2023-04-102024-03-3114789436bus:AbridgedAccounts2023-04-102024-03-3114789436bus:PrivateLimitedCompanyLtd2023-04-102024-03-3114789436core:WithinOneYear2024-03-3114789436core:AfterOneYear2024-03-3114789436core:WithinOneYear2023-04-0914789436core:AfterOneYear2023-04-0914789436core:ShareCapital2024-03-3114789436core:SharePremium2024-03-3114789436core:RevaluationReserve2024-03-3114789436core:OtherReservesSubtotal2024-03-3114789436core:RetainedEarningsAccumulatedLosses2024-03-3114789436core:ShareCapital2023-04-0914789436core:SharePremium2023-04-0914789436core:RevaluationReserve2023-04-0914789436core:OtherReservesSubtotal2023-04-0914789436core:RetainedEarningsAccumulatedLosses2023-04-0914789436core:LandBuildings2024-03-3114789436core:PlantMachinery2024-03-3114789436core:Vehicles2024-03-3114789436core:FurnitureFittings2024-03-3114789436core:OfficeEquipment2024-03-3114789436core:NetGoodwill2024-03-3114789436core:IntangibleAssetsOtherThanGoodwill2024-03-3114789436core:ListedExchangeTraded2024-03-3114789436core:UnlistedNon-exchangeTraded2024-03-3114789436core:LandBuildings2023-04-0914789436core:PlantMachinery2023-04-0914789436core:Vehicles2023-04-0914789436core:FurnitureFittings2023-04-0914789436core:OfficeEquipment2023-04-0914789436core:NetGoodwill2023-04-0914789436core:IntangibleAssetsOtherThanGoodwill2023-04-0914789436core:ListedExchangeTraded2023-04-0914789436core:UnlistedNon-exchangeTraded2023-04-0914789436core:LandBuildings2023-04-102024-03-3114789436core:PlantMachinery2023-04-102024-03-3114789436core:Vehicles2023-04-102024-03-3114789436core:FurnitureFittings2023-04-102024-03-3114789436core:OfficeEquipment2023-04-102024-03-3114789436core:NetGoodwill2023-04-102024-03-3114789436core:IntangibleAssetsOtherThanGoodwill2023-04-102024-03-3114789436core:ListedExchangeTraded2023-04-102024-03-3114789436core:UnlistedNon-exchangeTraded2023-04-102024-03-3114789436core:MoreThanFiveYears2023-04-102024-03-3114789436core:Non-currentFinancialInstruments2024-03-3114789436core:Non-currentFinancialInstruments2023-04-0914789436dpl:CostSales2023-04-102024-03-3114789436dpl:DistributionCosts2023-04-102024-03-3114789436core:LandBuildings2023-04-102024-03-3114789436core:PlantMachinery2023-04-102024-03-3114789436core:Vehicles2023-04-102024-03-3114789436core:FurnitureFittings2023-04-102024-03-3114789436core:OfficeEquipment2023-04-102024-03-3114789436dpl:AdministrativeExpenses2023-04-102024-03-3114789436core:NetGoodwill2023-04-102024-03-3114789436core:IntangibleAssetsOtherThanGoodwill2023-04-102024-03-3114789436dpl:GroupUndertakings2023-04-102024-03-3114789436dpl:ParticipatingInterests2023-04-102024-03-3114789436dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-102024-03-3114789436core:ListedExchangeTraded2023-04-102024-03-3114789436dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-102024-03-3114789436core:UnlistedNon-exchangeTraded2023-04-102024-03-3114789436dpl:CostSales2023-04-092023-04-0914789436dpl:DistributionCosts2023-04-092023-04-0914789436core:LandBuildings2023-04-092023-04-0914789436core:PlantMachinery2023-04-092023-04-0914789436core:Vehicles2023-04-092023-04-0914789436core:FurnitureFittings2023-04-092023-04-0914789436core:OfficeEquipment2023-04-092023-04-0914789436dpl:AdministrativeExpenses2023-04-092023-04-0914789436core:NetGoodwill2023-04-092023-04-0914789436core:IntangibleAssetsOtherThanGoodwill2023-04-092023-04-0914789436dpl:GroupUndertakings2023-04-092023-04-0914789436dpl:ParticipatingInterests2023-04-092023-04-0914789436dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-092023-04-0914789436core:ListedExchangeTraded2023-04-092023-04-0914789436dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-092023-04-0914789436core:UnlistedNon-exchangeTraded2023-04-092023-04-0914789436core:NetGoodwill2024-03-3114789436core:IntangibleAssetsOtherThanGoodwill2024-03-3114789436core:LandBuildings2024-03-3114789436core:PlantMachinery2024-03-3114789436core:Vehicles2024-03-3114789436core:FurnitureFittings2024-03-3114789436core:OfficeEquipment2024-03-3114789436core:AfterOneYear2024-03-3114789436core:WithinOneYear2024-03-3114789436core:ListedExchangeTraded2024-03-3114789436core:UnlistedNon-exchangeTraded2024-03-3114789436core:ShareCapital2024-03-3114789436core:SharePremium2024-03-3114789436core:RevaluationReserve2024-03-3114789436core:OtherReservesSubtotal2024-03-3114789436core:RetainedEarningsAccumulatedLosses2024-03-3114789436core:NetGoodwill2023-04-0914789436core:IntangibleAssetsOtherThanGoodwill2023-04-0914789436core:LandBuildings2023-04-0914789436core:PlantMachinery2023-04-0914789436core:Vehicles2023-04-0914789436core:FurnitureFittings2023-04-0914789436core:OfficeEquipment2023-04-0914789436core:AfterOneYear2023-04-0914789436core:WithinOneYear2023-04-0914789436core:ListedExchangeTraded2023-04-0914789436core:UnlistedNon-exchangeTraded2023-04-0914789436core:ShareCapital2023-04-0914789436core:SharePremium2023-04-0914789436core:RevaluationReserve2023-04-0914789436core:OtherReservesSubtotal2023-04-0914789436core:RetainedEarningsAccumulatedLosses2023-04-0914789436core:NetGoodwill2023-04-0914789436core:IntangibleAssetsOtherThanGoodwill2023-04-0914789436core:LandBuildings2023-04-0914789436core:PlantMachinery2023-04-0914789436core:Vehicles2023-04-0914789436core:FurnitureFittings2023-04-0914789436core:OfficeEquipment2023-04-0914789436core:AfterOneYear2023-04-0914789436core:WithinOneYear2023-04-0914789436core:ListedExchangeTraded2023-04-0914789436core:UnlistedNon-exchangeTraded2023-04-0914789436core:ShareCapital2023-04-0914789436core:SharePremium2023-04-0914789436core:RevaluationReserve2023-04-0914789436core:OtherReservesSubtotal2023-04-0914789436core:RetainedEarningsAccumulatedLosses2023-04-0914789436core:AfterOneYear2023-04-102024-03-3114789436core:WithinOneYear2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:CostValuation2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-102024-03-3114789436core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114789436core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114789436core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114789436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114789436core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114789436core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114789436core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114789436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114789436core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114789436core:Non-currentFinancialInstrumentscore:CostValuation2023-04-0914789436core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-0914789436core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-0914789436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-0914789436core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-0914789436core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-0914789436core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-0914789436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-0914789436core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-0914789436bus:Director12023-04-102024-03-3114789436bus:Director22023-04-102024-03-31

RL DENTAL LIMITED

Registered Number
14789436
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2024

RL DENTAL LIMITED
Company Information
for the period from 10 April 2023 to 31 March 2024

Directors

ILYAS, Louise Marie
ILYAS, Mohammad Razwan

Registered Address

6 Molescroft Road
Beverley
HU17 7DU

Registered Number

14789436 (England and Wales)
RL DENTAL LIMITED
Statement of Financial Position
31 March 2024

Notes

2024

£

£

Fixed assets
Tangible assets370,991
70,991
Current assets
Debtors421,233
Cash at bank and on hand35,286
56,519
Creditors amounts falling due within one year5(43,013)
Net current assets (liabilities)13,506
Total assets less current liabilities84,497
Creditors amounts falling due after one year6(37,416)
Provisions for liabilities8(17,748)
Net assets29,333
Capital and reserves
Called up share capital100
Profit and loss account29,233
Shareholders' funds29,333
The financial statements were approved and authorised for issue by the Board of Directors on 31 July 2024, and are signed on its behalf by:
ILYAS, Mohammad Razwan
Director
Registered Company No. 14789436
RL DENTAL LIMITED
Notes to the Financial Statements
for the period ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)Straight line (years)
Plant and machinery20-
Vehicles20-
Office Equipment-3
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

2024
Average number of employees during the year3
3.Tangible fixed assets

Total

£
Cost or valuation
Additions89,864
At 31 March 2489,864
Depreciation and impairment
Charge for year18,873
At 31 March 2418,873
Net book value
At 31 March 2470,991
At 09 April 23-
4.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables21,024
Prepayments and accrued income209
Total21,233
5.Creditors: amounts due within one year

2024

£
Trade creditors / trade payables5,570
Bank borrowings and overdrafts215
Taxation and social security22,641
Finance lease and HP contracts13,999
Accrued liabilities and deferred income588
Total43,013
6.Creditors: amounts due after one year

2024

£
Other creditors37,416
Total37,416
7.Obligations under finance leases

2024

£
Finance lease and HP contracts37,416
8.Provisions for liabilities

2024

£
Net deferred tax liability (asset)17,748
Total17,748
9.Related party transactions
During the year the directors loaned the company £214.80. The loan was interest free and repayable upon demand.